Bayer: Credit Suisse resumes coverage with 'Neutral' rating
(CercleFinance.com) - Credit Suisse analystd this morning said that they are resuming coverage of the Bayer share with a "Neutral" recommendation, along with a target price of 60 euros.
"We believe that the long-term prospects for the Ag division are good, with near-term synergies from the Monsanto-Bayer merger and long-term growth driven by important new launches from the mid-2020s," the broker says.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
"We believe that the long-term prospects for the Ag division are good, with near-term synergies from the Monsanto-Bayer merger and long-term growth driven by important new launches from the mid-2020s," the broker says.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.